Mostrar el registro sencillo

dc.contributor.authorAmpuero, Javier
dc.contributor.authorAller, Rocío
dc.contributor.authorCrespo García, Javier 
dc.contributor.authorCalleja, José Luis
dc.contributor.authorGarcía-Monzón, Carmelo
dc.contributor.authorGómez-Camarero, Judith
dc.contributor.authorCaballería, Joan
dc.contributor.authorLo Iacono, Oreste
dc.contributor.authorIbáñez, Luis
dc.contributor.authorGarcía-Samaniego, Javier
dc.contributor.authorAlbillos, Agustín
dc.contributor.authorFrancés, Rubén
dc.contributor.authorFernández-Rodríguez, Conrado
dc.contributor.authorMaya-Miles, Douglas
dc.contributor.authorDiago, Moisés
dc.contributor.authorPoca, María
dc.contributor.authorAndrade, Raúl J.
dc.contributor.authorLatorre, Raquel
dc.contributor.authorJorquera, Francisco
dc.contributor.authorMorillas, Rosa María
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-06-11T15:55:10Z
dc.date.available2024-06-11T15:55:10Z
dc.date.issued2024
dc.identifier.issn0944-1174
dc.identifier.issn1435-5922
dc.identifier.urihttps://hdl.handle.net/10902/33032
dc.description.abstractBackground: MASLD can manifest as hepatocellular damage, which can result in mild elevation of aminotransferases. However, in some patients, MASLD presents with cholestatic pattern. Objective: To assess the impact of the biochemical pattern on the natural course of MASLD, including liver damage in histology, the accuracy of non-invasive tests(NITs), and prognosis. Methods: Multicenter study enrolling 2156 patients with biopsy-proven MASLD, who were classified based on their[ALT/ULN)]/[(ALP/ULN)] levels at the time of biopsy: (a) hepatocellular pattern(H),>5; (b) mixed pattern(M),2-5; (c) cholestatic pattern(C),<2. Outcomes: (a) histological evaluation of the single components of NAS, MASH, and fibrosis; (b) NITs and transient elastography assessing advanced fibrosis; (c) prognosis determined by the appearance of decompensated cirrhosis and death. Results: Out of the 2156 patients, 22.9% exhibited the H-pattern, whilst 31.7% exhibited the C-pattern. Severe steatosis, ballooning, lobular inflammation, and MASH (56.4% H vs. 41.9% M vs. 31.9% C) were more common in H-pattern (p=0.0001),whilst C-pattern was linked to cirrhosis (5.8% H vs. 5.6% M vs. 10.9% C; p=0.0001). FIB-4(0.74(95% CI 0.69-0.79) vs. 0.83 (95% CI 0.80-0.85); p=0.005) and Hepamet Fibrosis Score(0.77 (95% CI 0.69-0.85) vs. 0.84 (95% CI 0.80-0.87); p=0.044)exhibited lower AUROCs in the H-pattern. The C-pattern[HR 2.37 (95% CI 1.12-5.02); p=0.024], along with age, diabetes, and cirrhosis were independently associated with mortality. Most patients maintained their initial biochemical pattern during the second evaluation. Conclusions: The H-pattern exhibited greater necro-inflammation in the histology than the C-pattern, whereas the latter showed more cirrhosis. The accuracy of NITs in detecting fibrosis was decreased in H-pattern. The occurrence of decompensated events and mortality was predominant in C-pattern. Therefore, identifying MASLD phenotypes based on the biochemical presentation could be relevant for clinical practice.es_ES
dc.description.sponsorshipFunding: Funding for open access publishing: Universidad de Sevilla/ CBUA. JA is funded by the “Spanish Ministry of Economy, Innovation and Competition, Instituto de Salud Carlos III” (PI19/01404, PI22/01345, and GLD19/00100). JMB is funded by Spanish Carlos III Health Institute (ISCIII) (FIS PI18/01075, PI21/00922 and Miguel Servet Program CPII19/00008) cofnanced by “Fondo Europeo de Desarrollo Regional” (FEDER), Department of Health of the Basque Country (2017111010, 2020111077), “Euskadi RIS3” (2022333032), La Caixa Scientifc Foundation (HR17-00601), European Union’s Horizon 2020 Research and Innovation Program (grant number 825510, ESCALON). PA is funded by Gobierno Vasco IT1476-22; MCIU/AEI/ FEDER, UE (PDI2021-124425OB-I00). *The funders have not had any role in the design, analysis, writing, or interpretation of this project.es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherSpringer Naturees_ES
dc.rights© The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holderes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Gastroenterology, 2024es_ES
dc.subject.otherHepatocellulares_ES
dc.subject.otherCholestasises_ES
dc.subject.otherMASLDes_ES
dc.subject.otherPhenotypeses_ES
dc.subject.otherTransaminaseses_ES
dc.titleThe biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1007/s00535-024-02098-8
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holderExcepto si se señala otra cosa, la licencia del ítem se describe como © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder